FTRE
FTRE
NASDAQ · Life Sciences Tools & Services

Fortrea Holdings Inc

$17.66
+0.64 (+3.76%)
Analyst Consensus
Buy
17
Analysts
High
Coverage
Buy 10 59%
Hold 6 35%
Sell 1 6%
Price Target
Analyst Price Target +165.1% upside
Low Target $29.35
Average Target $46.82
High Target $58.56
Current Price $17.66
Current
$17.66
Target
$46.82
$29.35 $46.82 avg $58.56
Scenario Analysis
Bear Case
$29.35
66.2%
Low target
Base Case
$46.82
+165.1%
Avg target
Bull Case
$58.56
+231.6%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$18.67
-5.4% from high
52-Week Low
$4.36
+305.5% from low
Target vs 52W High
$46.82
+150.8% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 34 85% $369.21 -27.0%
DHR
Danaher Corp
Strong Buy 30 90% $158.11 -18.9%
A
Agilent Technologies Inc
Strong Buy 28 79% $64.69 -50.9%
WAT
Waters Corp
Buy 28 57% $189.60 -49.5%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -55.7%
ILMN
Illumina Inc
Buy 28 61% $169.36 -5.0%
WST
West Pharmaceutical Services
Strong Buy 22 82% $136.24 -60.9%
MTD
Mettler-Toledo International
Hold 20 50% $170.43 -86.3%